BRNS Stock Analysis: Buy, Sell, or Hold?
BRNS - Barinthus Biotherapeutics plc American Depositary Shares
$0.70
0.03 (4.38%)
▲
5d:
-2.72%
30d:
+2.98%
90d:
+11.35%
BUY
HIGH Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When BRNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BRNS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: BRNS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: BRNS is currently trading at $0.70, which is considered slightly high relative to its 30-day fair value range of $0.67 to $0.71.
Technical Outlook: Technically, BRNS is showing sideways momentum. Immediate support is located at $0.64, while resistance sits at $0.74. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: BRNS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.50 (+685.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BRNS is showing sideways momentum. Immediate support is located at $0.64, while resistance sits at $0.74. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: BRNS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.50 (+685.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.67 -
$0.71
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.4%)
- BULLISH: Trading 685.3% below Wall St target ($5.50)
Trading Range Analysis
30-Day Trading Range
$0.67 -
$0.71
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.64
Resistance Level
$0.74
Current Trend
Sideways
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.61
Wall Street Target
$5.50
(+685.3%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 16, 2026 1:06 AM ET
Data refreshes hourly during market hours. Next update: 2:06 AM
Data refreshes hourly during market hours. Next update: 2:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$102 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 55 HOLD |
